secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001493152-24-019864
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical Q1 revenue up 55% to $27.9M; raises FY2024 revenue guidance to $116M-$120M
--------------------------------------------------------------------------------

- Revenue of $27.9M, up 55% YoY from $17.9M.
- Net loss of $4.4M ($0.03 per share) vs $2.1M loss in prior year.
- Positive Adjusted EBITDA of $0.1M vs -$0.3M a year ago.
- Gross margin improved 340 bps to 62.1%.
- Full year 2024 revenue guidance raised to $116M-$120M from $112M-$116M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224019864/0001493152-24-019864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224019864/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-019864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer